MedPath

Comparison of three techniques in the management of the postoperatory acute pain, after a general anesthesia based on the control of the nociceptio

Phase 1
Active, not recruiting
Conditions
Acute postoperative pain
MedDRA version: 19.0Level: LLTClassification code 10002323Term: Anesthesia generalSystem Organ Class: 100000004865
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2016-002824-98-ES
Lead Sponsor
Fundació Hospital Vall Hebron Institut de Recerca
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Recruiting
Sex
All
Target Recruitment
204
Inclusion Criteria

- Patients with ages between 18-75 years.
- ASA I-II-III.
- Body mass index (BMI ) less than 35 kg / m2 for women and 42 kg / m2 in men.
- Major gynecological surgery abdominal hysterectomy laparoscopic or robotic radical prostatectomy.
- Control Technology -TCI general anesthesia TIVA (total intravenous anesthesia by infusion systems controlled by computer).
- Patients enroll in other clinical investigations can participate
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 154
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 50

Exclusion Criteria

- Patients who do not accept their participation in this clinical trial.
- Patients who do not have legal capacity.
- Morbid obesity (BMI > 35 kg / m2 in women and > 42 kg / m2 in men).
- Basal values ??of systolic blood pressure = 95 mmHg or a heart rate = 60x ' .
-Disorders of conduct or anxiety-depressive syndrome.
- Treatment with chronic psychotropic drugs or opiates.
- Pregnancy
- Background Of alcohol abuse .
- Documented allergy to morphic drugs , paracetamol, metamizol and dexketoprofen.
- Visual secondary alterations to neurological pathologies, retinopatía diabetic and surgery or anomalies of the iris.
- Neurological impairment at the level of the midbrain.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath